The Low DoseThe GLP-1 price desk
Briefing

Hims & Hers vs Ro

$238/mo against $448/mo for tirzepatide. Which is worth it, and for whom.

Updated 2026-09-18

DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.

Both sell tirzepatide. Hims & Hers costs $238 a month and Ro costs $448, a difference of $210 a month or about $2,520 a year. The desk reads it as follows.

Hims & Hers is widest range of formats. Ro is branded medication with insurance help. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Side by side

Hims & HersRo
Advertised from$199$149
Membership on top$39/mo$149/mo
True monthly cost$238$448
Roughly, per year$2,856$5,376
Price includes medicationYesYes
Names its pharmacyNot publishedN/A — FDA-approved product
Our score3.5 / 53.5 / 5

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

Where Hims & Hers wins

  • One account covers oral, compounded injectable and branded options.
  • Large enough to keep supply steady when smaller sellers run dry.
  • Branded Zepbound is available without leaving the platform.

The advertised entry prices and the membership are separate charges. Add $39/month to whatever medication figure you were quoted.

Where Ro wins

  • FDA-approved medication only, which removes the compounding-regulation question entirely.
  • Genuine help pursuing insurance coverage.
  • Clear that medication is not included in the membership.

The membership and the medication are two separate bills. A $39 first month does not mean a $39 prescription.

How they score

What we weighWeightHims & HersRo
True monthly cost30%3.42.4
Price honesty20%3.23.8
Clinical support20%3.64.1
Pharmacy sourcing15%3.94.8
Cancelling15%3.33.4

Hims & Hers scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which should you pick?

  • Pick Hims & Hers if cost is the binding constraint. Over a year the gap is about $2,520, which is real money for the same class of medication.
  • Pick Ro if what it does better matters to you — fda-approved medication only, which removes the compounding-regulation question entirely.
  • Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Hims & Hers at $238 a month is the more defensible choice on arithmetic alone. Ro earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Hims & Hers and Ro.

How they sit against everyone else

ProgrammeAdvertisedBilledGapVs board floor
Coreage Rx$149$199+$50+$74/mo
Trimi$125$125none
Ozari Health$125$125none
Fifty 410$133$133none+$8/mo
PlexusDx$129$189+$60+$64/mo
Ivím Health$199$199none+$74/mo
Zealthy$216$216none+$91/mo
Hims & Hers$199$238+$39+$113/mo
Coby Health$179$239+$60+$114/mo
Mochi Health$199$278+$79+$153/mo
Eden$199$298+$99+$173/mo
Lemonaid Health$229$348+$119+$223/mo

More from the desk

  • Hims & Hers tirzepatide review

    Advertised at $199, billed at $238. Position 8 of 18 on our board.

  • Ro tirzepatide review

    Advertised at $149, billed at $448. Position 17 of 18 on our board.

  • How to spot a bad seller

    The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

  • The twelve-month cost

    Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

  • Cheapest right now

    Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.